Back to today’s briefing

Story perspectives

FDA Reviews Zyn Nicotine Pouches Amid Health Concerns

1/22/2026

33 7

Summary

Story summary

The U.S. Food and Drug Administration (FDA) is reviewing Philip Morris International's request to market Zyn nicotine pouches as a less harmful alternative to cigarettes.
A public meeting on Thursday will let health experts evaluate the company's claims that Zyn reduces the risk of smoking-related illnesses.
FDA scientists preliminarily support the claims but note the absence of long-term health studies on Zyn users.

1 of 1

Story summary

The U.S. Food and Drug Administration (FDA) is reviewing Philip Morris International's request to market Zyn nicotine pouches as a less harmful alternative to cigarettes.
A public meeting on Thursday will let health experts evaluate the company's claims that Zyn reduces the risk of smoking-related illnesses.
FDA scientists preliminarily support the claims but note the absence of long-term health studies on Zyn users.